NCT06282874 2026-04-09
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Phase 4 Active not recruiting
Guangdong Association of Clinical Trials
Fudan University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Hebei Medical University
Hebei Medical University
Hebei Medical University